These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1659506)

  • 21. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
    Mabilangan C; Preiksaitis JK; Cervera C;
    Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants.
    Arbustini E; Grasso M; Diegoli M; Percivalle E; Grossi P; Bramerio M; Campana C; Goggi C; Gavazzi A; Vigano M
    Am J Clin Pathol; 1992 Aug; 98(2):205-13. PubMed ID: 1324600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.
    Potena L; Solidoro P; Patrucco F; Borgese L
    Expert Opin Pharmacother; 2016 Aug; 17(12):1611-22. PubMed ID: 27340928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganciclovir nucleotide analysis in human myocardial tissue. Usefulness in the diagnosis of cytomegalovirus myocarditis.
    Boulieu R; Bleyzac N; Bastien O
    Adv Exp Med Biol; 1994; 370():483-5. PubMed ID: 7660953
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart transplant pathology: the British experience.
    Pomerance A; Stovin PG
    J Clin Pathol; 1985 Feb; 38(2):146-59. PubMed ID: 2981905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ganciclovir-resistant cytomegalovirus infection in transplanted patients: utility of drug monitoring.
    Esposito P; Bedino G; Montagna F; Gregorini M; Rampino T; Dal Canton A
    Transpl Infect Dis; 2013 Jun; 15(3):E122-3. PubMed ID: 23551712
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytomegalovirus infection and prophylaxis in heart transplantation.
    Laske A; Gallino A; Carrel T; Niederhäuser U; von Segesser LK; Turina MI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1427-8. PubMed ID: 8382870
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation.
    Macdonald PS; Keogh AM; Marshman D; Richens D; Harvison A; Kaan AM; Spratt PM
    J Heart Lung Transplant; 1995; 14(1 Pt 1):32-8. PubMed ID: 7727473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.
    Potena L; Holweg CT; Vana ML; Bashyam L; Rajamani J; McCormick AL; Cooke JP; Valantine HA; Mocarski ES
    J Clin Microbiol; 2007 Jun; 45(6):1804-10. PubMed ID: 17409205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
    Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Giant cell myocarditis--a rare, but dangerous disease].
    Aarønaes M; Haugaa KH; Andreassen AK; Simonsen S; Strøm EH; Geiran O
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2198-201. PubMed ID: 16138135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors.
    Sabé N; González-Costello J; Rama I; Niubó J; Bodro M; Roca J; Cruzado JM; Manito N; Carratalà J
    Transpl Int; 2012 Jul; 25(7):e78-82. PubMed ID: 22574951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cell myocarditis: first report of disease recurrence in the transplanted heart.
    Gries W; Farkas D; Winters GL; Costanzo-Nordin MR
    J Heart Lung Transplant; 1992; 11(2 Pt 1):370-4. PubMed ID: 1576144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens.
    Costanzo-Nordin MR; Winters GL; Fisher SG; O'Sullivan J; Heroux AL; Kao W; Mullen GM; Johnson MR
    J Heart Lung Transplant; 1993; 12(5):741-7. PubMed ID: 8241211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric cytomegalovirus infection in bone marrow transplant patients: an indication of generalized disease.
    Strayer DS; Phillips GB; Barker KH; Winokur T; DeSchryver-Kecskemeti K
    Cancer; 1981 Sep; 48(6):1478-83. PubMed ID: 6268285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gastrointestinal cytomegalovirus infection in patients with heart transplants].
    Lund MB; Simonsen S; Foerster A; Rollag H; Geiran O
    Tidsskr Nor Laegeforen; 1991 Nov; 111(28):3385-7. PubMed ID: 1665254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
    Ho WG; Winston DJ; Champlin RE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.